EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)

Chunxiao Li, Ting Li, Xinya Tian, Wei An, Zhenlong Wang, Bing Han, Hui Tao, Jinquan Wang, Xiumin Wang

Frontiers in Pharmacology · 08.03.2024 · 15

DOI: 10.3389/fphar.2024.1353626 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.03.2024. Verfasst von Chunxiao Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing, China. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the rapid advancement of genetic and protein engineering, proteins and peptides have emerged as promising drug molecules for therapeutic applications. Consequently, there has been a growing interest in the field of chemical modification technology to address challenges associated with their clinical use, including rapid clearance from circulation, immunogenicity, physical and chemical instabilities (such as aggregation, adsorption, deamination, clipping, oxidation, etc.), and enzymatic degradation. Polyethylene glycol (PEG) modification offers an effective solution to these issues due to its favorable properties. This review presents recent progress in the development and application of PEGylated therapeutic proteins and peptides (TPPs). For this purpose, firstly, the physical and chemical properties as well as classification of PEG and its derivatives are described. Subsequently, a detailed summary is provided on the main sites of PEGylated TPPs and the factors that influence their PEGylation. Furthermore, notable instances of PEG-modified TPPs (including antimicrobial peptides (AMPs), interferon, asparaginase and antibodies) are highlighted. Finally, we propose the chemical modification of TPPs with PEG, followed by an analysis of the current development status and future prospects of PEGylated TPPs. This work provides a comprehensive literature review in this promising field while facilitating researchers in utilizing PEG polymers to modify TPPs for disease treatment.

Schlagwörter

Stichwörter der Autor:innen

PEGylationantibodiesantimicrobial peptidesmodificationtherapeutic protein

Autor:innen und Institutionen

  • Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing, China.
  • Key Laboratory of Feed Biotechnology, Ministry of Agriculture and Rural Affairs, Beijing, China.
  • State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, Beijing, China.

Zitieren

APA

Li, C., Li, T., Tian, X., An, W., Wang, Z., Han, B., Tao, H., Wang, J., & Wang, X. (2024). Research progress on the PEGylation of therapeutic proteins and peptides (TPPs). Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1353626

Vancouver

Li C, Li T, Tian X, An W, Wang Z, Han B, et al. Research progress on the PEGylation of therapeutic proteins and peptides (TPPs). Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1353626

BibTeX
@article{Li2024,
  author = {Li, Chunxiao and Li, Ting and Tian, Xinya and An, Wei and Wang, Zhenlong and Han, Bing and Tao, Hui and Wang, Jinquan and Wang, Xiumin},
  title = {Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1353626}
}
Kostenlos starten →